<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>PC298372</GBSeq_locus>
    <GBSeq_length>4385</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>26-JUL-2024</GBSeq_update-date>
    <GBSeq_create-date>26-JUL-2024</GBSeq_create-date>
    <GBSeq_definition>JP 2021503945-A/4304: MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA</GBSeq_definition>
    <GBSeq_primary-accession>PC298372</GBSeq_primary-accession>
    <GBSeq_accession-version>PC298372.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|PC298372.1|</GBSeqid>
      <GBSeqid>pat|JP|2021503945|4304</GBSeqid>
      <GBSeqid>gi|2858950972</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>JP 2021503945-A/4304</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Adeno-associated virus 9</GBSeq_source>
    <GBSeq_organism>Adeno-associated virus 9</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Quintoviricetes; Piccovirales; Parvoviridae; Parvovirinae; Dependoparvovirus; Dependoparvovirus primate1</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..4385</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Takeuchi,R.</GBAuthor>
          <GBAuthor>Scaria,A.</GBAuthor>
          <GBAuthor>Noma,A.</GBAuthor>
          <GBAuthor>Kantardzhieva,A.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA</GBReference_title>
        <GBReference_journal>JP2021503945-A 4304 15-FEB-2021 CRISPR THERAPEUTICS AG,BAYER HEALTHCARE LLC</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>OS Adeno-associated virus 9~PN JP 2021503945-A/4304~PD 15-FEB-2021~PF 21-NOV-2018 JP 2020545012~PR 29-AUG-2018 US 62/724319 ,28-MAR-2018 US 62/649133~PR ,~PR 02-JUL-2018 US 62/693080 ,21-NOV-2017 US 62/589111~PA CRISPR THERAPEUTICS AG,BAYER HEALTHCARE LLC~PI ryo takeuchi,abraham scaria,akiko noma,albena kantardzhieva~PT 'MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT~PT RETINITIS~PT PIGMENTOSA'~PS N5134~CC~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..4385</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>4385</GBInterval_to>
            <GBInterval_accession>PC298372.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Adeno-associated virus 9</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:235455</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>cagagagggagtggccaactccatcactaggggtaatcgcgaagcgcctcccacgctgccgcgtcagcgctgacgtagattacgtcataggggagtggtcctgtattagctgtcacgtgagtgcttttgcgacattttgcgacaccacatggccatttgaggtatatatggccgagtgagcgagcaggatctccattttgaccgcgaaatttgaacgagcagcagccatgccgggcttctacgagattgtgatcaaggtgccgagcgacctggacgagcacctgccgggcatttctgactcttttgtgaactgggtggccgagaaggaatgggagctgcccccggattctgacatggatcggaatctgatcgagcaggcacccctgaccgtggccgagaagctgcagcgcgacttcctggtccaatggcgccgcgtgagtaaggccccggaggccctcttctttgttcagttcgagaagggcgagagctactttcacctgcacgttctggtcgagaccacgggggtcaagtccatggtgctaggccgcttcctgagtcagattcgggagaagctggtccagaccatctaccgcgggatcgagccgaccctgcccaactggttcgcggtgaccaagacgcgtaatggcgccggcggggggaacaaggtggtggacgagtgctacatccccaactacctcctgcccaagactcagcccgagctgcagtgggcgtggactaacatggaggagtatataagcgcgtgcttgaacctggccgagcgcaaacggctcgtggcgcagcacctgacccacgtcagccagacgcaggagcagaacaaggagaatctgaaccccaattctgacgcgcccgtgatcaggtcaaaaacctccgcgcgctacatggagctggtcgggtggctggtggaccggggcatcacctccgagaagcagtggatccaggaggaccaggcctcgtacatctccttcaacgccgcctccaactcgcggtcccagatcaaggccgcgctggacaatgccggcaagatcatggcgctgaccaaatccgcgcccgactacctggtaggcccttcacttccggtggacattacgcagaaccgcatctaccgcatcctgcagctcaacggctacgaccctgcctacgccggctccgtctttctcggctgggcacaaaagaagttcgggaaacgcaacaccatctggctgtttgggccggccaccacgggaaagaccaacatcgcagaagccattgcccacgccgtgcccttctacggctgcgtcaactggaccaatgagaactttcccttcaacgattgcgtcgacaagatggtgatctggtgggaggagggcaagatgacggccaaggtcgtggagtccgccaaggccattctcggcggcagcaaggtgcgcgtggaccaaaagtgcaagtcgtccgcccagatcgaccccactcccgtgatcgtcacctccaacaccaacatgtgcgccgtgattgacgggaacagcaccaccttcgagcaccagcagcctctccaggaccggatgtttaagttcgaactcacccgccgtctggagcacgactttggcaaggtgacaaagcaggaagtcaaagagttcttccgctgggccagtgatcacgtgaccgaggtggcgcatgagttttacgtcagaaagggcggagccagcaaaagacccgcccccgatgacgcggataaaagcgagcccaagcgggcctgcccctcagtcgcggatccatcgacgtcagacgcggaaggagctccggtggactttgccgacaggtaccaaaacaaatgttctcgtcacgcgggcatgcttcagatgctgcttccctgcaaaacgtgcgagagaatgaatcagaatttcaacatttgcttcacacacggggtcagagactgctcagagtgtttccccggcgtgtcagaatctcaaccggtcgtcagaaagaggacgtatcggaaactctgtgcgattcatcatctgctggggcgggctcccgagattgcttgctcggcctgcgatctggtcaacgtggacctggatgactgtgtttctgagcaataaatgacttaaaccaggtatggctgccgatggttatcttccagattggctcgaggacaacctctctgagggcattcgcgagtggtgggcgctgaaacctggagccccgaagcccaaagccaaccagcaaaagcaggacgacggccggggtctggtgcttcctggctacaagtacctcggacccttcaacggactcgacaagggggagcccgtcaacgcggcggacgcagcggccctcgagcacggcaaggcctacgaccagcagctgcaggcgggtgacaatccgtacctgcggtataaccacgccgacgccgagtttcaggagcgtctgcaagaagatacgtcttttgggggcaacctcgggcgagcagtcttccaggccaagaagcgggttctcgaacctctcggtctggttgaggaaggcgctaagacggctcctggaaagaagagaccggtagagccatcaccccagcgttctccagactcctctacgggcatcggcaagaaaggccaacagcccgccagaaaaagactcaattttggtcagactggcgactcagagtcagttccagaccctcaacctctcggagaacctccagcagcgccctctggtgtgggacctaatacaatggctgcaggcggtggcgcaccaatggcagacaataacgaaggcgccgacggagtgggtaattcctcgggaaattggcattgcgattccacatggctgggggacagagtcatcaccaccagcacccgaacctgggcattgcccacctacaacaaccacctctacaagcaaatctccaatggaacatcgggaggaagcaccaacgacaacacctactttggctacagcaccccctgggggtattttgacttcaacagattccactgccacttctcaccacgtgactggcagcgactcatcaacaacaactggggattccggccaaagagactcaacttcaagctgttcaacatccaggtcaaggaggttacgacgaacgaaggcaccaagaccatcgccaataaccttaccagcaccgtccaggtctttacggactcggagtaccagctaccgtacgtcctaggctctgcccaccaaggatgcctgccaccgtttcctgcagacgtcttcatggttcctcagtacggctacctgacgctcaacaatggaagtcaagcgttaggacgttcttctttctactgtctggaatacttcccttctcagatgctgagaaccggcaacaactttcagttcagctacactttcgaggacgtgcctttccacagcagctacgcacacagccagagtctagatcgactgatgaaccccctcatcgaccagtacctatactacctggtcagaacacagacaactggaactgggggaactcaaactttggcattcagccaagcaggccctagctcaatggccaatcaggctagaaactgggtacccgggccttgctaccgtcagcagcgcgtctccacaaccaccaaccaaaataacaacagcaactttgcgtggacgggagctgctaaattcaagctgaacgggagagactcgctaatgaatcctggcgtggctatggcatcgcacaaagacgacgaggaccgcttctttccatcaagtggcgttctcatatttggcaagcaaggagccgggaacgatggagtcgactacagccaggtgctgattacagatgaggaagaaattaaagccaccaaccctgtagccacagaggaatacggagcagtggccatcaacaaccaggccgctaacacgcaggcgcaaactggacttgtgcataaccagggagttattcctggtatggtctggcagaaccgggacgtgtacctgcagggccctatttgggctaaaatacctcacacagatggcaactttcacccgtctcctctgatgggtggatttggactgaaacacccacctccacagattctaattaaaaatacaccagtgccggcagatcctcctcttaccttcaatcaagccaagctgaactctttcatcacgcagtacagcacgggacaagtcagcgtggaaatcgagtgggagctgcagaaagaaaacagcaagcgctggaatccagagatccagtatacttcaaactactacaaatctacaaatgtggactttgctgtcaataccaaaggtgtttactctgagcctcgccccattggtactcgttacctcacccgtaatttgtaattgcctgttaatcaataaaccggttaattcgtttcagttgaactttggtctctgcg</GBSeq_sequence>
  </GBSeq>
